It is noted that the European Commission in agreement with the EU leaders made a decision that the contracts with the companies that produce vaccines that act in 2021 will not be extended after their expiry.
Meanwhile, Brussels intends to focus on Pfizer and Moderna vaccines.
Besides, the official EU representative stated that the European Commission demands explanations from J&J Company on an ‘unexpected’ delay in drug supplies to the EU.
On April 6, the EMA representative confirmed there is a connection between the AstraZeneca vaccine against coronavirus and the development of blood clots in the patients' bodies.
The first messages about side effects after vaccination with AstraZeneca (Vaxzevria) appeared in early March. Austria was the first to state it suspends the vaccination with the use of this drug. Later, more than 20 countries did the same.